Disseminated BCG infection in BCG immuno
β
M. Rahima; M. Topilsky; B. I. Shnider; C. Srulijes; Z. Keinan
π
Article
π
1979
π
Springer-Verlag
π
English
β 128 KB
Nonspecific immunotherapy with BCG has become an established modality of treatment in malignant melanoma since Math+ introduced it in 1962 [4,5]. Local and nonspecific complications are common and well documented. Cases of disseminated BCG infection, however, are rare and, if unrecognized and untrea